Blackhawk Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Buy
+1,611
New +$189K 0.07% 132
2021
Q2
Sell
-24,150
Closed -$1.89M 105
2021
Q1
$1.89M Buy
24,150
+482
+2% +$35.6K 1.42% 21
2020
Q4
$1.87M Buy
23,668
+7,576
+47% +$579K 1.6% 17
2020
Q3
$1.19M Buy
16,092
+1,880
+13% +$147K 1.08% 35
2020
Q2
$1.04M Buy
+14,212
New +$1.07M 1.24% 30
2019
Q1
Sell
-15,102
Closed -$1.1M 90
2018
Q4
$1.1M Sell
15,102
-3,331
-18% -$235K 1.4% 31
2018
Q3
$1.25M Sell
18,433
-457
-2% -$29.1K 1.76% 23
2018
Q2
$1.09M Sell
18,890
-2,025
-10% -$114K 1.24% 22
2018
Q1
$1.09M Buy
20,915
+20,433
+4,239% +$1.1M 0.92% 30
2017
Q4
$26K Buy
+482
New +$26.7K 0.02% 200

Other funds holding MRK

Blackhawk Capital Partners's MRK Position: Q2 2026 in Review

Blackhawk Capital Partners opened a new position in Merck (MRK) in Q2 2026: 1,611 shares worth $207K. The stake represents 0.07% of the portfolio and ranks #132 among its holdings. This is a return to the name: Blackhawk Capital Partners previously reported a position in MRK as recently as Q1 2021.

Blackhawk Capital Partners first reported a position in MRK in Q4 2017 and has held it in 10 quarters since. The position peaked at $1.89M in Q1 2021. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Blackhawk Capital Partners held 1,611 shares of Merck worth $207K as of Q2 2026.
  • Merck was a new Blackhawk Capital Partners position in Q2 2026.
  • Merck made up 0.07% of Blackhawk Capital Partners's portfolio in Q2 2026, its #132 holding.
  • Blackhawk Capital Partners first reported a position in Merck in Q4 2017 and has held it in 10 quarters since.
  • Blackhawk Capital Partners's Merck position peaked at $1.89M in Q1 2021.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Blackhawk Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.